Literature DB >> 19030167

Is biopsy always necessary? Toward a clinico-laboratory approach for diagnosing nonalcoholic steatohepatitis in obesity.

Enzo Emanuele.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19030167     DOI： 10.1002/hep.22622

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  11 in total

1.  Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.

Authors:  Raj Vuppalanchi; Robert J Gould; Laura A Wilson; Aynur Unalp-Arida; Oscar W Cummings; Naga Chalasani; Kris V Kowdley
Journal:  Hepatol Int       Date:  2011-05-10       Impact factor: 6.047

Review 2.  Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis.

Authors:  Yusuf Yilmaz; Alla Eldeen Kedrah; Osman Ozdogan
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

3.  Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD).

Authors:  Erifili Hatziagelaki; Christian Herder; Anastasia Tsiavou; Tom Teichert; Athina Chounta; Peter Nowotny; Giovanni Pacini; George Dimitriadis; Michael Roden
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

4.  The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection.

Authors:  Zhiqiao Zhang; Gongsui Wang; Kaifu Kang; Guobiao Wu; Peng Wang
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

5.  Diagnostic accuracy and clinical utility of a new noninvasive index for hepatic steatosis in patients with hepatitis B virus infection.

Authors:  Zhiqiao Zhang; Gongsui Wang; Kaifu Kang; Guobiao Wu; Peng Wang
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

6.  Nomogram for cirrhosis in patients with chronic hepatitis B: A simple self-assessed scale for individual risk of cirrhosis.

Authors:  Zhiqiao Zhang; Jing Li; Peng Wang; Tingshan He; Yanling Ouyang; Yiyan Huang
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

7.  Application of Machine Learning Techniques for Clinical Predictive Modeling: A Cross-Sectional Study on Nonalcoholic Fatty Liver Disease in China.

Authors:  Han Ma; Cheng-Fu Xu; Zhe Shen; Chao-Hui Yu; You-Ming Li
Journal:  Biomed Res Int       Date:  2018-10-03       Impact factor: 3.411

8.  Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example.

Authors:  Sandra Page; Aybike Birerdinc; Michael Estep; Maria Stepanova; Arian Afendy; Emanuel Petricoin; Zobair Younossi; Vikas Chandhoke; Ancha Baranova
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

9.  Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.

Authors:  Raika Jamali; Abbas Arj; Mohsen Razavizade; Mohammad Hossein Aarabi
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

10.  Association of gamma-glutamyl transferase with subclinical coronary atherosclerosis and cardiac outcomes in non-alcoholics.

Authors:  Yong-Giun Kim; Gyung-Min Park; Seung Bum Lee; Dong Hyun Yang; Joon-Won Kang; Tae-Hwan Lim; Hong-Kyu Kim; Jaewon Choe; Seung-Whan Lee; Young-Hak Kim
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.